Physician profile
Billy M Pickering
NPI 1487762787
$1,679.76
in general payments reported to CMS, 2019-2025
21 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $296 · 2020: $258 · 2021: $234 · 2022: $258 · 2023: $223 · 2024: $193 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $368.00 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.69 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $186.83 | 2020-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $186.67 | 2021-2023 | |
| Amgen INC. | $95.97 | 2020-2025 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $86.87 | 2019-2021 | |
| Novo Nordisk INC | $68.28 | 2024-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $66.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $53.76 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Sanofi-Aventis U.S. LLC | $46.62 | 2019-2023 | |
| Astellas Pharma US INC | $44.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.80 | 2024 | Jardiance |
| Amarin Pharma, INC. | $36.28 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $25.02 | 2020-2021 | |
| Abbott Laboratories | $21.55 | 2023 | Freestyle Libre 2 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.69 | 2023 | |
| Medtronic, INC. | $19.60 | 2022 | |
| Exact Sciences Corporation | $18.17 | 2025 | The Cologuard Plus Collection Kit |
| Idorsia Pharmaceuticals US INC | $16.37 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.25 | 2019 | |
| Allergan, INC. | $11.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Billy Pickering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.